Theriva Biologics
TOVX
TOVX
20 hedge funds and large institutions have $452K invested in Theriva Biologics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24.9K | |
| 2 | +$17K | |
| 3 | +$13K | |
| 4 |
LNC
Lincoln National Corp
Radnor,
Pennsylvania
|
+$4.73K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.61K |
Top Sellers
| 1 | -$62.9K | |
| 2 | -$8.61K | |
| 3 | -$6.78K | |
| 4 |
BlackRock
New York
|
-$54 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$54 |